1Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis. A randomized controlled trial[ J]. JAMA. 2004,291:1071-1080
5Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterollowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Abstract[ J]. Lancet, 2005,366:1267-1278
6Pedersen TR, Faergeman O, Kastelein JJP, et al. the Incremental Decrease in Evems through Aggressive Lipid Lowering (IDEAL) Study Group. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction. The IDEAL study: a randomized controlled trial[J]. JAMA, 2005; 294 : 2437 -2445
